SINGAPORE – French pharmaceutical company, Sanofi has begun construction on the first of two so-called Evolutive Vaccine Facilities (EVFs) it is constructing with a total investment of 900 million euros…
Read MoreTag: Sanofi
Sanofi India appoints Rodolfo Hrosz managing director effective June 1
INDIA –Sanofi India (SIL) announced that Rodolfo Hrosz has been appointed as the Company’s new Managing Director, effective June 1, 2022, subject to regulatory approvals. He will move from his…
Read MoreSanofi and IGM team up to develop IgM antibody agonists for six targets
FRANCE – Sanofi and IGM Biosciences have formed an exclusive global partnership to create, develop, manufacture, and commercialize immunoglobulin M (IgM) antibody agonists for oncology, immunology, and inflammation targets. The…
Read MoreBlackstone funds Sanofi’s new trials to develop subcutaneous form of Sarclisa
FRANCE – Sanofi and Blackstone Life Sciences have announced a risk-sharing agreement in which Blackstone Life Sciences will contribute up to €300 million (US$330 million) to fund the development of…
Read MoreS&P recognizes Sanofi as one of the most sustainability-committed companies
FRANCE – Sanofi has been named one of the most sustainable companies in an ESG (Environment, Social, Governance) evaluation conducted by Standard & Poor’s Global Ratings (S&P). Sanofi received an…
Read MoreDarioHealth signs US$30 million strategic agreement with Sanofi US
USA –DarioHealth Corp., a global digital therapeutics (DTx) provider, announced a US$30 million multi-year strategic agreement with Sanofi U.S., an innovative global healthcare company. The multi-year, US $30 million agreement…
Read MoreSanofi inks US$2.5 billion deal with Adagene to develop cancer antibodies
FRANCE – China’s Adagene Inc, a Nasdaq-listed innovative biopharmaceutical company focused on the discovery and development of antibody-based novel cancer immunotherapy has announced a collaboration and signed an exclusive license…
Read MorePfizer-Valneva Lyme vaccine poised for phase 3 trials
USA – Pfizer Inc. and Valneva SE, have announced additional positive Phase 2 data for their Lyme disease vaccine candidate, VLA15, the only Lyme disease vaccine candidate currently in clinical…
Read MoreFDA approves Sanofi’s Enjaymo for treatment of rare blood disease
FRANCE – The US FDA has approved Enjaymo (sutimlimab-jome) infusion to reduce the need for red blood cell transfusion due to hemolysis (red blood cell destruction) in adults with cold…
Read MoreRegeneron and Sanofi pull Libtayo’s application for cervical cancer treatment
FRANCE – Regeneron Pharmaceuticals Inc and its partner Sanofi voluntarily withdrew their application to the US Food and Drug Administration to expand the use of their anti-cancer drug Libtayo in…
Read More